Qube Research & Technologies (QRT)
FTH

Qube Research & Technologies (QRT)’s Faeth Therapeutics FTH Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio FTH Stock Details FTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Hold
0
– -$2 – 4041
2024
Q2 		– Hold
0
– – – 3696
2024
Q1 		– Hold
0
– – – 4342
2023
Q4 		– Hold
0
– – – 4231
2023
Q3 		– Hold
0
– – – 3995
2022
Q4 		– Sell
-836
Closed -$26K – 2953
2022
Q3 		$26K Sell
836
-102
-11% -$4.01K ﹤0.01% 2264
2022
Q2 		$43K Buy
+938
New +$35.1K ﹤0.01% 2153

Other funds holding FTH

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Qube Research & Technologies (QRT)'s FTH Position: Q3 2024 in Review

Qube Research & Technologies (QRT) held its Faeth Therapeutics (FTH) position steady in Q3 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4041.

Qube Research & Technologies (QRT) first reported a position in FTH in Q2 2022 and has held it in 2 quarters since. The position peaked at $43K in Q2 2022. 19 funds tracked by Wall St. Rank hold FTH as of Q3 2024.

  • Qube Research & Technologies (QRT) held 0 shares of Faeth Therapeutics worth $0 as of Q3 2024.
  • Qube Research & Technologies (QRT) left its Faeth Therapeutics share count unchanged in Q3 2024.
  • Faeth Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2024, its #4041 holding.
  • Qube Research & Technologies (QRT) first reported a position in Faeth Therapeutics in Q2 2022 and has held it in 2 quarters since.
  • Qube Research & Technologies (QRT)'s Faeth Therapeutics position peaked at $43K in Q2 2022.
  • 19 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.